Ewing sarcoma (EWS) is the second most common pediatric bone tumor. The EWS tumor microenvironment is largely recognized as immune-cold, with macrophages being the most abundant immune cells and their presence associated with worse patient prognosis. Expression of CD99 is a hallmark of EWS cells, and its targeting induces inhibition of EWS tumor growth through a poorly understood mechanism. In this study, we analyzed CD99 expression and functions on macrophages and investigated whether the concomitant targeting of CD99 on both tumor and macrophages could explain the inhibitory effect of this approach against EWS. Targeting CD99 on EWS cells downregulated expression of the "don't eat-me" CD47 molecule but increased levels of the "eat-me" phosphatidyl serine and calreticulin molecules on the outer leaflet of the tumor cell membrane, triggering phagocytosis and digestion of EWS cells by macrophages. In addition, CD99 ligation induced reprogramming of undifferentiated M0 macrophages and M2-like macrophages toward the inflammatory M1-like phenotype. These events resulted in the inhibition of EWS tumor growth. Thus, this study reveals what we believe to be a previously unrecognized function of CD99, which engenders a virtuous circle that delivers intrinsic cell death signals to EWS cells, favors tumor cell phagocytosis by macrophages, and promotes the expression of various molecules and cytokines, which are pro-inflammatory and usually associated with tumor regression. This raises the possibility that CD99 may be involved in boosting the antitumor activity of macrophages.

Engagement of CD99 activates distinct programs in Ewing sarcoma and macrophages / Manara, Maria Cristina; Manferdini, Cristina; Cristalli, Camilla; Carrabotta, Marianna; Santi, Spartaco; De Feo, Alessandra; Caldoni, Giulia; Pasello, Michela; Landuzzi, Lorena; Lollini, Pier-Luigi; Salamanna, Francesca; Dominici, Sabrina; Fiori, Valentina; Magnani, Mauro; Lisignoli, Gina; Scotlandi, Katia. - In: CANCER IMMUNOLOGY RESEARCH. - ISSN 2326-6066. - STAMPA. - 12:(2024), pp. 1-14. [10.1158/2326-6066.CIR-23-0440]

Engagement of CD99 activates distinct programs in Ewing sarcoma and macrophages

Carrabotta, Marianna;Lollini, Pier-Luigi;
2024

Abstract

Ewing sarcoma (EWS) is the second most common pediatric bone tumor. The EWS tumor microenvironment is largely recognized as immune-cold, with macrophages being the most abundant immune cells and their presence associated with worse patient prognosis. Expression of CD99 is a hallmark of EWS cells, and its targeting induces inhibition of EWS tumor growth through a poorly understood mechanism. In this study, we analyzed CD99 expression and functions on macrophages and investigated whether the concomitant targeting of CD99 on both tumor and macrophages could explain the inhibitory effect of this approach against EWS. Targeting CD99 on EWS cells downregulated expression of the "don't eat-me" CD47 molecule but increased levels of the "eat-me" phosphatidyl serine and calreticulin molecules on the outer leaflet of the tumor cell membrane, triggering phagocytosis and digestion of EWS cells by macrophages. In addition, CD99 ligation induced reprogramming of undifferentiated M0 macrophages and M2-like macrophages toward the inflammatory M1-like phenotype. These events resulted in the inhibition of EWS tumor growth. Thus, this study reveals what we believe to be a previously unrecognized function of CD99, which engenders a virtuous circle that delivers intrinsic cell death signals to EWS cells, favors tumor cell phagocytosis by macrophages, and promotes the expression of various molecules and cytokines, which are pro-inflammatory and usually associated with tumor regression. This raises the possibility that CD99 may be involved in boosting the antitumor activity of macrophages.
2024
Engagement of CD99 activates distinct programs in Ewing sarcoma and macrophages / Manara, Maria Cristina; Manferdini, Cristina; Cristalli, Camilla; Carrabotta, Marianna; Santi, Spartaco; De Feo, Alessandra; Caldoni, Giulia; Pasello, Michela; Landuzzi, Lorena; Lollini, Pier-Luigi; Salamanna, Francesca; Dominici, Sabrina; Fiori, Valentina; Magnani, Mauro; Lisignoli, Gina; Scotlandi, Katia. - In: CANCER IMMUNOLOGY RESEARCH. - ISSN 2326-6066. - STAMPA. - 12:(2024), pp. 1-14. [10.1158/2326-6066.CIR-23-0440]
Manara, Maria Cristina; Manferdini, Cristina; Cristalli, Camilla; Carrabotta, Marianna; Santi, Spartaco; De Feo, Alessandra; Caldoni, Giulia; Pasello, Michela; Landuzzi, Lorena; Lollini, Pier-Luigi; Salamanna, Francesca; Dominici, Sabrina; Fiori, Valentina; Magnani, Mauro; Lisignoli, Gina; Scotlandi, Katia
File in questo prodotto:
File Dimensione Formato  
CD99 Mac cir-23-0440 opt.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione 596.74 kB
Formato Adobe PDF
596.74 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/954628
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact